Recently Featured
Bayer drug packaging for stroke prevention

FDA Approves Bayer’s Sunharbo to Reduce Stroke Recurrence

November 10, 2026
The Food and Drug Administration approved Bayer’s drug Sunharbo to reduce recurrence of stroke. This drug is the first in a novel class of medications aimed at preventing blood clots more safely. Many blood thinners are not used in this setting due to the increased risk of bleeding. Sunharbo inhibits a protein called XIa, which…
Manufacturing facility for pharmaceuticals

Trump Administration Removes WuXi AppTec from Military List

November 10, 2026
The Trump administration removed WuXi AppTec from its list of “Chinese military companies” operating in the U.S. This decision follows a court ruling last August that temporarily blocked the designation after WuXi filed a lawsuit claiming it was arbitrary and capricious under the Administrative Procedure Act. Previously, the administration had placed WuXi AppTec on the…
Scientist working in a cancer research lab

iDEL Therapeutics Partners with Daiichi Sankyo on Cancer Drug Delivery

November 10, 2026
iDEL Therapeutics has entered a multi-year research collaboration with Daiichi Sankyo to investigate a new approach to delivering combination cancer therapies directly into solid tumor cells. The agreement will focus on the preclinical evaluation of a multi-drug conjugate (MDC) developed using iDEL’s synthetic shuttle technology. Researchers from iDEL and Daiichi Sankyo’s Research Institute Munich will…
Scientist using AI technology in a lab

Sanofi Advances AI Protein Design for Drug Discovery

November 10, 2026
Sanofi is advancing its AI-based protein design program from proof-of-concept to real-world drug discovery. Norbert Furtmann, PhD, head of biologics AI and design at Sanofi, outlines a three-pronged approach: foundational models, property prediction and virtual screening, and de novo design. The foundational models team creates sequence- and structure-based models trained on public and in-house data.…

Ongoing Cases